Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.17B 918M 786M 736M 673M 1.26B 87.81B 1.28B 8.69B 3.39B 44.11B 3.45B 3.37B 146B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7.04B 1.05B 898M 840M 769M 1.44B 100B 1.46B 9.92B 3.87B 50.37B 3.93B 3.85B 167B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 week-2.16%
Current month-1.74%
1 month+2.49%
3 months-4.24%
6 months+3.67%
Current year+3.91%
1 week 4.44
Extreme 4.44
4.62
1 month 4.36
Extreme 4.36
4.85
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.44
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.12
Manager TitleAgeSince
Chief Executive Officer 56 02/04/2015
Director of Finance/CFO 41 29/12/2020
Corporate Officer/Principal 42 27/01/2014
Director TitleAgeSince
Chairman 56 27/03/2026
Director/Board Member 58 25/12/2007
Director/Board Member 42 27/01/2014
Date Insider Type Main position Quantity % Market Cap.
21/9/20 Sell

Chairman

1,940,600 0.2495%
18/9/20 Sell

Director

3,670,000 0.4719%
18/9/20 Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.16%-26.38%-42.05% 918M
-1.75%-1.40%-14.42%-5.44% 13.09B
-2.74%-2.90%-35.91%-57.41% 4.85B
-6.30%-6.88%-7.32%-5.58% 4.59B
-5.35%-3.01%+1.29%-28.48% 4.09B
-2.56%-2.27%-24.04%+0.57% 3.51B
-2.87%-0.49%-11.37%-7.54% 3.34B
-3.23%-2.35%-12.30%+11.55% 3.33B
-4.14%-2.45%-18.19%-15.33% 2.43B
-3.92%-3.50%-30.34%-14.40% 1.67B
Average -3.29%-2.58%-17.90%-16.41% 4.18B
Weighted average by Cap. -3.18%-2.33%-16.11%-13.78%

Financials

2024 2025
Net sales 3.83B 569M 487M 456M 418M 784M 54.45B 794M 5.39B 2.1B 27.35B 2.14B 2.09B 90.47B 3.05B 454M 388M 363M 333M 624M 43.39B 633M 4.29B 1.67B 21.8B 1.7B 1.67B 72.1B
Net income 33.62M 5M 4.28M 4.01M 3.67M 6.89M 479M 6.98M 47.36M 18.47M 240M 18.78M 18.37M 795M -104M -15.53M -13.3M -12.44M -11.39M -21.38M -1.49B -21.66M -147M -57.33M -746M -58.3M -57.03M -2.47B
Net Debt 1.4B 208M 178M 167M 153M 287M 19.93B 291M 1.97B 769M 10.01B 782M 765M 33.12B 875M 130M 111M 104M 95.46M 179M 12.45B 182M 1.23B 480M 6.25B 489M 478M 20.68B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
21/08/26 CN¥4.520 0.00% 5,323,250
20/08/26 CN¥4.520 +1.12% 7,437,500
19/08/26 CN¥4.470 -1.97% 8,807,100
18/08/26 CN¥4.560 -0.65% 5,855,000
17/08/26 CN¥4.590 -0.65% 5,815,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock